The NMCC initiated an investigation on possible anti-competitive practices in the manufacturing and distribution of medical gases, consisting of market sharing, price fixing and the
The Spanish Competition Authority closes the medical gases investigation due to insufficient evidence to establish anticompetitive practices (Abelló Linde / Air Liquide Medicinal / Conste / Praxair...)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.